Cellulitis is commonly misdiagnosed and may be incorrectly applied as a diagnosis in 1 in 3 cases. There are many causes of ‘pseudocellulitis’, including: stasis dermatitis, acute lipodermatosclerosis, lymphedema, eczematous dermatitis, contact dermatitis, gout and tinea pedis. The most common among these is stasis dermatitis which generally affects the bilateral lower legs. In the setting of bilateral lower leg skin changes, causes of ‘pseudocellulitis’ should be considered.
Levell NJ, et al. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011 Jun;164(6):1326-8. PMID: 21564054.
Baibergenova A, et al. Hospitalizations for cellulitis in Canada: a database study. J Cutan Med Surg. 2014 Jan-Feb;18(1):33-7. PMID: 24377471.
Ko LN, et al. Effect of Dermatology Consultation on Outcomes for Patients With Presumed Cellulitis: A Randomized Clinical Trial. JAMA Dermatol. 2018 May 1;154(5):529-536. PMID: 29453872.
Hirschmann JV, et al. Lower limb cellulitis and its mimics: part II. Conditions that simulate lower limb cellulitis. J Am Acad Dermatol. 2012 Aug;67(2):177.e1-9. PMID: 22794816.
Topical corticosteroid/antifungal products in cream or ointment formulations contain high-potency corticosteroids generally considered inappropriate for skin conditions affecting the face and skin folds. These have been prescribed for suspected superficial fungal infections and diaper dermatitis. However, evidence demonstrates inferior clinical efficacy, higher recurrence rates and harmful side effects (skin thinning and systemic absorption) compared to topical antifungals alone. In practice, their use may complicate diagnosis and prolong treatment. Suspicion of fungal infection should be confirmed by skin scraping, and fungal infections with substantial itch may be treated with a short-term topical mild to moderate corticosteroid prescription.
Greenberg HL, et al. Clotrimazole/betamethasone dipropionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol. 2002 Jan-Feb;19(1):78-81. PMID: 11860579.
Alston SJ, et al. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents. Pediatrics. 2003;111(1):201-3. PMID: 12509578.
Wheat CM, et al. Current trends in the use of two combination antifungal/corticosteroid creams. Pediatrics. 2017 Jul;186:192-195. PMID: 28438376.
Post-surgical wounds in dermatology may be closed with stitches or allowed to heal in from the base. Most dermatologic procedures result in wounds that are classified as ‘non-contaminated’ and have low baseline potential for infection. For wounds closed with stitches, the potential harms (allergic contact dermatitis to topical ingredients, antibiotic resistance) outweigh the marginal reduced risk of postoperative infection achieved by use of antibiotics applied to the skin. Only wounds that show symptoms of infection (purulence, swelling, spreading redness, wound breakdown and systemic symptoms) should receive appropriate antibiotic treatment.
Saco M, et al. Topical antibiotic prophylaxis for prevention of surgical wound infections from dermatologic procedures: a systematic review and meta-analysis. J Dermatolog Treat. 2015 Apr;26(2):151-8. PMID: 24646178.
Gehrig KA, et al. Allergic contact dermatitis to topical antibiotics: Epidemiology, responsible allergens, and management. J Am Acad Dermatol. 2008 Jan;58(1):1-21. PMID: 18158924.
Norman G, et al. Antibiotics and antiseptics for surgical wounds healing by secondary intention. Cochrane Database Syst Rev. 2016 Mar 29;3:CD011712. PMID: 27021482.
Fungal nail infections account for half of all causes of nail changes (onychodystrophy). The other half can be attributed to conditions such as onychogryphosis (secondary nail thickening), psoriasis and lichen planus. Health care providers vary in their ability to correctly predict fungal toenail infections which can be confirmed by simple microscopy, fungal culture, or histology. Systemic antifungals indicated for moderate to severe nail infection can result in a variety of drug-drug interactions and confer increased risk for heart and liver failure. Confirming a fungal infection can prevent unnecessary treatment with avoidable harms and guide the diagnosis of other possible causes.
Gupta AK, et al. Confirmatory testing prior to initiating onychomycosis therapy is cost-effective. J Cutan Med Surg. 2018 Mar/Apr;22(2):129-141. PMID: 28954534.
Ameen M, et al. British Association of Dermatologists’ guidelines for the management of onychomycosis 2014. Br J Dermatol. 2014 Nov;171(5):937-58. PMID: 25409999.
Vender RB, et al. Prevalence and epidemiology of onychomycosis. J Cutaneous Med Surg. 2006 Nov;10(6):S28-S33.
Gupta AK, et al. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017 Nov/Dec;21(6):525–539. PMID: 28639462.
Antibiotics are the most common systemic agent prescribed for the treatment of acne, employed for their antibacterial and anti-inflammatory effect. Prolonged antibiotic courses can lead to disruption of the normal microbiome, increased rates of upper respiratory infection and has been linked to the development of other systemic disorders. There are also rising rates of antibiotic resistance to pathogenic acne bacteria. For moderate or more severe acne warranting systemic treatment, the effect of oral antibiotics should be reassessed after 3 months to gauge progress. If ineffective, treatment should be modified to other systemic medications such as anti-androgens (spironolactone), combined oral contraceptive pills or retinoids. Use of oral antibiotics should always be combined with topical benzoyl peroxide and/or a topical retinoid.
Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33. PMID: 26897386.
Asai Y, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016 Feb 2;188(2):118-26. PMID: 26573753.
Barbieri JS, et al. Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019 Feb;80(2):538-549. PMID: 30296534.
Barbieri JS, et al. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013. J Am Acad Dermatol. 2017 Sep;77(3):456-463.e4. PMID: 28676330.